In Brief: Ethicon buys UltraCision
This article was originally published in The Gray Sheet
Executive SummaryEthicon buys UltraCision: Johnson & Johnson subsidiary Ethicon Endo-Surgery acquires Rhode Island-based UltraCision, Inc., the manufacture of the Harmonic Scalpel, a device that employs ultrasound to "make surgical incisions with minimal tissue damage," Ethicon says. Terms of the deal were not disclosed. Introduced in 1992, the Harmonic Scalpel has been used in gallbladder removal, appendectomy, repair of hiatal hernia, hysterectomy, and bladder neck suspension procedures, according to Ethicon. Future uses may include "cardiac and vascular surgery; plastic and reconstructive surgery; dermatology; and arthroscopic surgery"...
You may also be interested in...
The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.
Cadila has filed for approval of saroglitazar for NASH in India. The drug, which could emerge as the first medicine for the indication if approved, is already being used by a million Indian patients for diabetic dyslipidemia and hypertriglyceridemia.
It has been a long and sometimes tortuous development path for Lupuzor but ImmuPharma's chief executive tells Scrip the company's faith in the lupus drug is bearing fruit.